Bio News
Researchers at Stanford University in the United States developed TIGRA, a compact gene-activation tool. TIGRA is less than half the size of existing CRISPR activation tools and can simultaneously activate up to 12 genes. In a mouse model of retinal ganglion cell damage, the researchers preserved approximately one-third of vision.
Biobook Team
biobookmedia@biobook.co.krParagon Spin-Off Velaris Goes Public Through Reverse Merger With Alaunos
Syndax halts development of Niktimvo for pulmonary fibrosis; shares plunge 17%
BioNTech’s mRNA Cancer Vaccine Misses Primary Endpoint for Progression-Free Survival in Phase 3 Trial
Roche Signs $1.6 Billion Deal With China’s Rona for ALK7 Obesity Drug
Formycon and Zydus’ Keytruda Biosimilar Is First to Be Accepted for FDA Review
Pfizer Signs $500 Million Protein Degrader Deal With Enodia
